{
    "Clinical Trial ID": "NCT00583700",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Control Arm",
        "  Watchful waiting (standard treatment). Study participants received no intervention and were monitored for development of radiation-induced fibrosis.",
        "INTERVENTION 2: ",
        "  Intervention: Pentoxifylline & Vitamin E",
        "  Combined treatment with Pentoxifylline and Vitamin E.",
        "  Vitamin E : Vitamin E (Over-the-counter) 400 I.U. once daily",
        "  Pentoxifylline : Pentoxifylline 400 mg, 3 times daily for 7 months, beginning immediately after radiation therapy."
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Patients with histologically documented cancer of the breast or DCIS or head and neck referred for definitive radiation with curative intent.",
        "  No evidence of metastatic disease.",
        "  Minimum life expectancy of at least 12 months.",
        "  Aged greater than 20 years.",
        "  If female, pregnancy excluded.",
        "  No documented history of collagen vascular disease.",
        "Exclusion Criteria:",
        "  Cognitively impaired patients",
        "  Prisoners",
        "  No histology available",
        "  Documented metastatic disease",
        "  Allergy to Trental",
        "  Life expectance of less than 12 months.",
        "  Aged less than 20 years",
        "  Collagen vascular disease present",
        "  Pregnant",
        "  History of liver disease",
        "  Use of anticoagulants"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Subjective, Objective, Management, and Analytic (SOMA) Score",
        "  A primary outcome of interest is the composite Subjective, Objective, Management, and Analytic (SOMA) score at 18-month follow-up visit. Maximum score is 45, with a score of 0 being ideal and representing no treatment-related side effects at the study visit.",
        "  Time frame: 18 month post-treatment",
        "Results 1: ",
        "  Arm/Group Title: Control Arm",
        "  Arm/Group Description: Watchful waiting (standard treatment). Study participants received no intervention and were monitored for development of radiation-induced fibrosis.",
        "  Overall Number of Participants Analyzed: 27",
        "  Mean (Standard Deviation)",
        "  Unit of Measure: units on a scale  1.59         (1.53)",
        "Results 2: ",
        "  Arm/Group Title: Intervention: Pentoxifylline & Vitamin E",
        "  Arm/Group Description: Combined treatment with Pentoxifylline and Vitamin E.",
        "  Vitamin E : Vitamin E (Over-the-counter) 400 I.U. once daily",
        "  Pentoxifylline : Pentoxifylline 400 mg, 3 times daily for 7 months, beginning immediately after radiation therapy.",
        "  Overall Number of Participants Analyzed: 25",
        "  Mean (Standard Deviation)",
        "  Unit of Measure: units on a scale  1.0         (1.19)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/27 (0.00%)",
        "Adverse Events 2:",
        "  Total: 0/27 (0.00%)"
    ]
}